Tuesday, June 30, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

CTKB — Cytek Biosciences, Inc. SEC Filings | FilingIndex

CTKBNasdaq

Cytek Biosciences, Inc.

Laboratory Analytical Instruments · DE · CIK 1831915

Cytek Biosciences advances cell analysis with Full Spectrum Profiling technology for deeper biological insights

red 8-K · 90d

+ Watch View on EDGAR ↗

$511M

Market cap

$4.34

Last close

-3.1%

1D

+12.4%

5D

1.1M

Volume

Price · last 39 sessions-6.9%

May 4L $3.35 · H $4.94Jun 29

88

Total filings

Jun 25, 2026

Last filing

12/31

Fiscal year end

All 8-K · 42 10-Q · 15 SC 13G · 9 DEF 14A · 5 DEFA14A · 5 10-K · 5 S-1/A · 2 8-K/A · 1

8-KExecutive ChangeJun 25, 2026 8-KShareholder VoteJun 16, 2026 8-KExecutive ChangeJun 2, 2026 8-KResults of OperationsMay 7, 2026 8-KResults of OperationsFeb 26, 2026 8-K

Similar companies

Comparable business profile · signals at a glance

MXCTMAXCYTE, INC.$120.0M0.0%TXG10x Genomics, Inc.$3.7B+1.1%MASS908 Devices Inc.$312.7M+0.3%PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC.$406.9M+4.8%BLLNBillionToOne, Inc.

Results of Operations

Jan 13, 2026

8-KResults of OperationsNov 5, 2025

8-KResults of OperationsAug 6, 2025

8-KShareholder VoteJun 24, 2025

8-KResults of OperationsMay 8, 2025

8-KResults of OperationsFeb 27, 2025

8-KResults of OperationsJan 15, 2025

8-KResults of OperationsNov 5, 2024

8-KExecutive ChangeSep 12, 2024

8-KResults of OperationsAug 6, 2024

8-KShareholder VoteJun 11, 2024

8-KResults of OperationsMay 8, 2024

8-KExecutive ChangeMar 19, 2024

8-KResults of OperationsMar 1, 2024

8-KExecutive ChangeFeb 27, 2024

8-KResults of OperationsJan 9, 2024

8-KReg FD DisclosureNov 28, 2023

8-KResults of OperationsNov 9, 2023

8-KResults of OperationsNov 7, 2023

8-KResults of OperationsAug 8, 2023

8-KShareholder VoteJun 20, 2023

8-KResults of OperationsMay 9, 2023

8-KResults of OperationsFeb 28, 2023

8-KAcquisition / DispositionFeb 28, 2023

8-KMaterial Agreement · Reg FD DisclosureFeb 13, 2023

8-KResults of OperationsNov 9, 2022

8-KExecutive ChangeNov 1, 2022

8-KResults of OperationsAug 10, 2022

8-KShareholder VoteJun 6, 2022

8-KResults of OperationsMay 11, 2022

8-KExecutive ChangeMar 2, 2022

8-KResults of OperationsFeb 23, 2022

8-KExecutive ChangeJan 6, 2022

8-KResults of OperationsNov 8, 2021

8-KResults of OperationsSep 3, 2021

8-KMaterial AgreementAug 30, 2021

8-KBylaw Amendment · Company UpdateJul 27, 2021

$4.7B

+1.9%

FLGTFulgent Genetics, Inc.$530.5M+2.9%